Clostridioides Difficile Infection Market Outlook & Forecast: Strategic Insights | Thelansis

Source Summary

Clostridioides difficile infection (CDI) is entering a new phase of innovation as microbiome therapeutics, targeted antibiotics, and prevention-focused strategies reshape a market long constrained by recurrence and limited treatment options. While conventional antibiotics remain the foundation of care, regulatory advances